Document Detail

Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond.
MedLine Citation:
PMID:  22836386     Owner:  NLM     Status:  Publisher    
It is now widely accepted that the angiotensin AT(2) receptor (AT(2)R) plays an important protective role during pathophysiologic conditions, acting as a repair system. The development of the first selective nonpeptide AT(2)R agonist C21 accelerated our understanding of AT(2)R-mediated protective signaling and actions. This article reviews the impact of C21 on blood pressure in normotensive and hypertensive animal models. Although C21 does not act as a classical antihypertensive drug, it could be useful in preventing hypertension-induced vascular and other end organ damages via anti-apoptotic, anti-fibrotic and anti-inflammatory actions. In particular, a strong body of evidence started to emerge around its anti-inflammatory feature. This property should be further investigated for potential clinical indications in cardiovascular diseases and beyond.
Sébastien Foulquier; U Muscha Steckelings; Thomas Unger
Related Documents :
11349386 - The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. a ...
21327946 - Fluid dynamics of heart development.
8593746 - Animal models of heart failure for pharmacological studies.
3436846 - Cardiac-related cortical activity during variations in mean heart rate.
21769456 - Optic nerve ultrasound for the detection of raised intracranial pressure.
18335316 - Hydrogel-based microsensors for wireless chemical monitoring.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-27
Journal Detail:
Title:  Current hypertension reports     Volume:  -     ISSN:  1534-3111     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Macrophage activation syndrome.
Next Document:  Nocturnal Medications Dosing: Does It Really Make a Difference in Blood Pressure Control Among Patie...